Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 USD | -7.24% | -20.00% | -6.10% |
05-06 | Curative Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million. | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
I. Garr
CEO | Chief Executive Officer | 71 | 10/02/21 |
Paul M. Michael
CHM | Chairman | - | - |
Steve Chizzik
IRC | Investor Relations Contact | - | - |
Ron Bordens
PRN | Corporate Officer/Principal | - | 10/02/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Cary Sucoff
BRD | Director/Board Member | 71 | 11/05/22 |
Theresa Heah
BRD | Director/Board Member | 46 | 03-30 |
Lawrence Zaslow
BRD | Director/Board Member | - | - |
Paul M. Michael
CHM | Chairman | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 227,000 | 0 | 0 | 99.92 % |
Stock B | 1 | 628,922,947 | 628,416,540 ( 99.92 %) | 0 | |
Stock C | 0 | 30,000,000 | 0 | 0 |
Company contact information
Curative Biotechnology, Inc.
3801 PGA Boulevard Suite 600
33410, Palm Beach Gardens
+
http://www.curativebiotech.comSector
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+50.13% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |
- Stock Market
- Equities
- CUBT Stock
- CUBT Stock
- Company CURE BIOT